140 related articles for article (PubMed ID: 2870837)
1. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
Zecchi P; Bellocci F; Santarelli P; Iannarelli M
Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
[No Abstract] [Full Text] [Related]
2. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
[No Abstract] [Full Text] [Related]
3. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
Del Re ML; Ricci A; Abate G
Clin Ter; 1986 Mar; 116(5):385-90. PubMed ID: 2871962
[No Abstract] [Full Text] [Related]
4. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
[No Abstract] [Full Text] [Related]
5. [Combined treatment of arterial hypertension. Comparison of a beta-blocker plus a saluretic combination with beta-blocker].
Rodatz KW; Hörder MH
MMW Munch Med Wochenschr; 1983 Feb; 125(7):136-8. PubMed ID: 6133217
[No Abstract] [Full Text] [Related]
6. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
Jackson DA
Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
[No Abstract] [Full Text] [Related]
7. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
O'Callaghan EG
Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
[No Abstract] [Full Text] [Related]
8. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
[TBL] [Abstract][Full Text] [Related]
9. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
Hill LS; Fand RS
Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
[No Abstract] [Full Text] [Related]
10. [Our experience on the clinical use of nadolol].
Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
[No Abstract] [Full Text] [Related]
11. Nadolol (corgard) in severe and resistant hypertension.
Nontak MA
Med J Malaysia; 1981 Sep; 36(3):181-5. PubMed ID: 6120443
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of the hypotensive effects of nadolol].
Hanzlik J; Sodolski W; Stelmasiak T; Wolański I
Kardiol Pol; 1982; 25(2):101-6. PubMed ID: 6125620
[No Abstract] [Full Text] [Related]
13. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Freis ED
Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
[TBL] [Abstract][Full Text] [Related]
14. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
[No Abstract] [Full Text] [Related]
15. Nadolol (Corgard) - a new beta-blocker.
Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
[No Abstract] [Full Text] [Related]
16. Mediation of blood pressure by nadolol and alpha methyldopa.
Jenkins AC; Rosenthal J; Stumpe KO
Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of nadolol in angina pectoris.
Cruz J; Conceicao JM; Coelho EM
Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
[No Abstract] [Full Text] [Related]
18. Prorenin and beta-blockade in hypertension.
McKenna F; Davison AM
Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
[TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive therapy with a fixed combination of beta receptor blockers and diuretics].
Kolloch R; Overlack A; Stumpe KO
Ther Ggw; 1979 Oct; 118(10):1517-28. PubMed ID: 40314
[No Abstract] [Full Text] [Related]
20. Nadolol: a new beta-adrenoceptor antagonist.
Frishman WH
N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
